{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T14:07:05Z","timestamp":1781878025579,"version":"3.54.5"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.yebeh.2024.110199","type":"journal-article","created":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T18:09:23Z","timestamp":1733940563000},"page":"110199","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Assessment of temporal changes in cognitive effects induced by antiseizure medications in epilepsy patients"],"prefix":"10.1016","volume":"163","author":[{"given":"\u00d6mer","family":"Karada\u015f","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javid","family":"Shafiyev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ak\u00e7ay \u00d6v\u00fcn\u00e7","family":"Karada\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U\u011fur Burak","family":"\u015eim\u015fek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bet\u00fcl","family":"\u00d6zen\u00e7","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6zlem Aksoy","family":"\u00d6zmenek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.yebeh.2024.110199_b0005","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0168-5597(98)00007-0","article-title":"Automatic and effortful processes in auditory memory reflected by event-related potentials age-related findings","volume":"108","author":"Amenedo","year":"1998","journal-title":"Electro Clin Neurophysiol\/Evoked Poten Sec"},{"issue":"1","key":"10.1016\/j.yebeh.2024.110199_b0010","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1528-1157.1987.tb03624.x","article-title":"Zonisamide (CI-912) and cognition: results from preliminary study","volume":"28","author":"Berent","year":"1987","journal-title":"Epilepsia"},{"issue":"5","key":"10.1016\/j.yebeh.2024.110199_b0015","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.seizure.2008.11.006","article-title":"The impact of side effects on long-term retention in three new antiepileptic drugs","volume":"18","author":"Bootsma","year":"2009","journal-title":"Seizure"},{"issue":"2","key":"10.1016\/j.yebeh.2024.110199_b0020","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/gps.4756","article-title":"A re\u2010examination of montreal cognitive assessment (MoCA) cutoff scores","volume":"33","author":"Carson","year":"2018","journal-title":"Int J Geriatr Psychiatry"},{"issue":"3","key":"10.1016\/j.yebeh.2024.110199_b0025","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1027\/1016-9040.2.3.247","article-title":"Age and information processing","volume":"2","author":"Czigler","year":"1997","journal-title":"Eur Psychol"},{"issue":"11","key":"10.1016\/j.yebeh.2024.110199_b0030","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1016\/j.clinph.2009.07.045","article-title":"Event-related potentials in clinical research: Guidelines for eliciting, recording, and quantifying mismatch negativity, P300, and N400","volume":"120","author":"Duncan","year":"2009","journal-title":"Clin Neurophysiol"},{"issue":"6","key":"10.1016\/j.yebeh.2024.110199_b0035","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1177\/1756285611417920","article-title":"The cognitive impact of antiepileptic drugs","volume":"4","author":"Eddy","year":"2011","journal-title":"Ther Adv Neurol Disord"},{"key":"10.1016\/j.yebeh.2024.110199_b0040","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.2147\/NDT.S256117","article-title":"Effects of levetiracetam compared to valproate on cognitive functions of patients with epilepsy","volume":"16","author":"El Sabaa","year":"2020","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"4","key":"10.1016\/j.yebeh.2024.110199_b0045","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1177\/2042098611411127","article-title":"New generation antiepileptic drugs: what do they offer in terms of improved tolerability and safety?","volume":"2","author":"French","year":"2011","journal-title":"Ther Adv Drug Saf"},{"issue":"3","key":"10.1016\/j.yebeh.2024.110199_b0050","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.yebeh.2007.02.007","article-title":"The influence of antiepileptic drugs on cognition: A comparison of levetiracetam with topiramate","volume":"10","author":"Gomer","year":"2007","journal-title":"Epilepsy Behav"},{"issue":"4","key":"10.1016\/j.yebeh.2024.110199_b0055","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1093\/brain\/101.4.635","article-title":"Long latency event-related components of the auditory evoked potential in dementia","volume":"101","author":"Goodin","year":"1978","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.yebeh.2024.110199_b0060","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.yebeh.2012.11.052","article-title":"The longer-term cognitive effects of adjunctive antiepileptic treatment with lacosamide in comparison with lamotrigine and topiramate in a naturalistic outpatient setting","volume":"26","author":"Helmstaedter","year":"2013","journal-title":"Epilepsy Behav"},{"issue":"6","key":"10.1016\/j.yebeh.2024.110199_b0065","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/ane.12372","article-title":"Cognitive effects of lacosamide as adjunctive therapy in refractory epilepsy","volume":"131","author":"IJff","year":"2015","journal-title":"Acta Neurol Scand"},{"issue":"3","key":"10.1016\/j.yebeh.2024.110199_b0070","doi-asserted-by":"crossref","first-page":"929","DOI":"10.3233\/JAD-160979","article-title":"The mild behavioral impairment checklist (MBI-C): A rating scale for neuropsychiatric symptoms inpre-dementia populations","volume":"56","author":"Ismail","year":"2017","journal-title":"J Alzheimer\u2019s Dis"},{"key":"10.1016\/j.yebeh.2024.110199_b0075","series-title":"Cochrane Database of Systematic Reviews","article-title":"Topiramate add-on for drug-resistant partial epilepsy","author":"Jette","year":"2008"},{"issue":"1","key":"10.1016\/j.yebeh.2024.110199_b0080","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/s12877-018-0951-8","article-title":"Montreal cognitive assessment reflects cognitive reserve","volume":"18","author":"Kang","year":"2018","journal-title":"BMC Geriatr"},{"issue":"4","key":"10.1016\/j.yebeh.2024.110199_b0085","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/WNF.0000000000000038","article-title":"Cognitive and psychosocial effects of oxcarbazepine monotherapy in newly diagnosed partial epilepsy","volume":"37","author":"Kim","year":"2014","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.yebeh.2024.110199_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2020.107580","article-title":"The effects of lacosamide on cognitive function and psychiatric profiles in patients with epilepsy","volume":"113","author":"Li","year":"2020","journal-title":"Epilepsy Behav"},{"issue":"4","key":"10.1016\/j.yebeh.2024.110199_b0095","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.yebeh.2005.08.015","article-title":"EpiTrack: Tracking cognitive side effects of medication on attention and executive functions in patients with epilepsy","volume":"7","author":"Lutz","year":"2005","journal-title":"Epilepsy Behav"},{"issue":"4","key":"10.1016\/j.yebeh.2024.110199_b0100","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.yebeh.2005.08.015","article-title":"EpiTrack: Tracking cognitive side effects of medication on attention and executive functions in patients with epilepsy","volume":"7","author":"Lutz","year":"2005","journal-title":"Epilepsy Behav"},{"issue":"8","key":"10.1016\/j.yebeh.2024.110199_b0105","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1212\/WNL.45.8.1494","article-title":"Comparative cognitive effects of phenobarbital, phenytoin, and valproate in healthy adults","volume":"45","author":"Meador","year":"1995","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.yebeh.2024.110199_b0110","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1212\/WNL.56.9.1177","article-title":"Differential cognitive and behavioral effects of carbamazepine and lamotrigine","volume":"56","author":"Meador","year":"2001","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.yebeh.2024.110199_b0115","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1345\/aph.1E136","article-title":"Clinical, cognitive, and neurophysiologic correlates of short-term treatment with carbamazepine, oxcarbazepine, and levetiracetam in healthy volunteers","volume":"38","author":"Mecarelli","year":"2004","journal-title":"Ann Pharmacother"},{"issue":"4","key":"10.1016\/j.yebeh.2024.110199_b0120","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.2038","article-title":"Cognitive dysfunction in Nigerian women with epilepsy on carbamazepine and levetiracetam monotherapy","volume":"11","author":"Ogunjimi","year":"2021","journal-title":"Brain and Behavior"},{"key":"10.1016\/j.yebeh.2024.110199_b0125","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.yebeh.2003.11.008","article-title":"Cognitive side effects of antiepileptic drugs","volume":"5","author":"Ortinski","year":"2004","journal-title":"Epilepsy Behav"},{"issue":"1","key":"10.1016\/j.yebeh.2024.110199_b0130","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.yebeh.2007.08.002","article-title":"Long-term cognitive and mood effects of zonisamide monotherapy in epilepsy patients","volume":"12","author":"Park","year":"2008","journal-title":"Epilepsy Behav"},{"issue":"3","key":"10.1016\/j.yebeh.2024.110199_b0135","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3988\/jcn.2008.4.3.99","article-title":"Cognitive effects of antiepileptic drugs","volume":"4","author":"Park","year":"2008","journal-title":"J Clin Neurol"},{"issue":"4","key":"10.1016\/j.yebeh.2024.110199_b0140","article-title":"Characterization of N200 and P300: selected studies of the event-related potential","volume":"2","author":"Patel","year":"2005","journal-title":"Int J Med Sci"},{"issue":"1","key":"10.1016\/j.yebeh.2024.110199_b0145","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0167-8760(00)00127-6","article-title":"P300 as a clinical assay: rationale, evaluation, and findings","volume":"38","author":"Polich","year":"2000","journal-title":"Int J Psychophysiol"},{"key":"10.1016\/j.yebeh.2024.110199_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2020.106906","article-title":"Antiepileptic drug effects on subjective and objective cognition","volume":"104","author":"Quon","year":"2020","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2024.110199_b0155","article-title":"Effect of antiepileptic drugs on P300 event-related potentials in patients with epilepsy","author":"\u0160ari\u0107 Juri\u0107","year":"2021","journal-title":"Acta Clin Croat"},{"key":"10.1016\/j.yebeh.2024.110199_b0160","doi-asserted-by":"crossref","DOI":"10.1007\/s10072-024-07606-5","article-title":"The assessment of the impact of antiepileptic drugs on cognitive functions via N-200\/P-300 potentials and neuropsychological measures","author":"Shafiyev","year":"2024","journal-title":"Neurol Sci"},{"key":"10.1016\/j.yebeh.2024.110199_b0165","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.eplepsyres.2019.01.004","article-title":"Cognitive, behavioural and sleep-related adverse effects on introduction of levetiracetam versus oxcarbazepine for epilepsy","volume":"150","author":"Thelengana","year":"2019","journal-title":"Epilepsy Res"},{"issue":"5","key":"10.1016\/j.yebeh.2024.110199_b0170","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1136\/jnnp.69.5.636","article-title":"Effects of topiramate on cognitive function","volume":"69","author":"Thompson","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152550502400581X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152550502400581X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T15:01:34Z","timestamp":1739458894000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152550502400581X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":34,"alternative-id":["S152550502400581X"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2024.110199","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of temporal changes in cognitive effects induced by antiseizure medications in epilepsy patients","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2024.110199","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110199"}}